MyFinsight
Home
About
Contact
slxn: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, SLXN has $11,614K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Assets
11,614
5,797
Equity, attributable to parent
6,977
120
Liabilities and equity
11,614
5,797
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Operating lease,
right-of-use asset
$442K
Property, plant and
equipment, net
$26K
Deposits assets,
noncurrent
$36K
Restricted cash,
noncurrent
$55K
Other assets, current
$47K
Prepaid expense,
current
$1,739K
Restricted cash and cash
equivalents, current
$26K
Cash and cash
equivalents, at carrying...
$9,243K
Assets, noncurrent
$559K
Assets, current
$11,055K
Assets
$11,614K
Liabilities and equity
$11,614K
Equity, attributable to
parent
$6,977K
Liabilities
$4,637K
Retained earnings
(accumulated deficit)
-$50,754K
Additional paid in capital
$57,689K
Liabilities, noncurrent
$1,851K
Liabilities, current
$2,786K
Common stock, value,
issued
$42K
Represent the amount of
promissory notes to related...
$1,540K
Operating lease,
liability, noncurrent
$311K
Other accounts
payable and accrued...
$945K
Employee-related liabilities,
current
$721K
Operating lease,
liability, current
$174K
Accounts payable,
current
$946K
Subscribe for Financial Insights
Silexion Therapeutics Corp (SLXN)
Silexion Therapeutics Corp (SLXN)